2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Breast Neoplasms
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
AZD 6244
19
trametinib
5
Lovastatin
5
Deoxycholic Acid
4
mirdametinib
3
Lasers, Solid-State
3
pirfenidone
2
fludarabine
2
binimetinib
2
Vincristine
2
Vinblastine
2
Transcranial Direct Current Stimulation
2
Specimen Handling
2
Sirolimus
2
Polidocanol
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Lasers
2
Lamotrigine
2
Inhalation
2
Everolimus
2
Carboplatin
2
Blood Specimen Collection
2
Biopsy
2
Acetylcysteine
2
tipifarnib
1
thymoglobulin
1
talimogene laherparepvec
1
pomalidomide
1
peginterferon alfa-2b
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
Neuropsychological Tests
×
Clear all
NCT01851135
2016-07-06
NF1-QDV
Nantes University Hospital
Phase NA
Completed
286 enrolled